US 7842704
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
granted A61KA61K31/439A61K31/445
Quick answer
US patent 7842704 (Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity) held by Theravance, Inc. expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/439, A61K31/445, A61K31/4545, A61P